{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:22Z","timestamp":1767135142453,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd014820","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000}}],"reference-count":78,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014820.pub2","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T06:58:34Z","timestamp":1726815514000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Erythropoiesis-stimulating agents for preventing acute kidney injury"],"prefix":"10.1002","volume":"2024","author":[{"given":"Hiroki","family":"Nishiwaki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine; Showa University Fujigaoka Hospital; Yokohama Japan"},{"name":"Institute of Clinical Epidemiology (iCE); Showa University; Tokyo Japan"},{"name":"Showa University Research Administration Center (SURAC); Showa University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Abe","sequence":"additional","affiliation":[{"name":"Children\u2019s Medical Center; Showa University Koto Toyosu Hospital; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taihei","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Showa University Graduate School of Medicine; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Institute of Clinical Epidemiology (iCE); Showa University; Tokyo Japan"},{"name":"Showa University Research Administration Center (SURAC); Showa University; Tokyo Japan"},{"name":"Department of Nephrology; Showa University Graduate School of Medicine; Tokyo Japan"},{"name":"Department of Hygiene, Public Health, and Preventive Medicine, Graduate School of Medicine; Showa University; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William MM","family":"Levack","sequence":"additional","affiliation":[{"name":"Rehabilitation Teaching and Research Unit, Department of Medicine; University of Otago; Wellington New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Noma","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Statistical Mathematics; The Institute of Statistical Mathematics; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Ota","sequence":"additional","affiliation":[{"name":"Global Health Nursing, Graduate School of Nursing Science; St. Luke's International University; Tokyo Japan"},{"name":"Tokyo Foundation for Policy Research; Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD014820.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00467-022-05474-9","article-title":"Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial","volume":"37","author":"Balestracci","year":"2022","journal-title":"Pediatriatric Nephrology"},{"issue":"22","key":"10.1002\/14651858.CD014820.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.288.22.2827","article-title":"Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial","volume":"288","author":"Corwin","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD014820.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0003-4975(97)00839-4","article-title":"Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients","volume":"64","author":"D'Ambra","year":"1997","journal-title":"Annals of Thoracic Surgery"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD014820.pub2-BIB0004|cit4","first-page":"127","article-title":"Epoetin does not demonstrate anti-inflammatory properties after cardiac surgery [abstract no:TH-PO068]","volume":"21","author":"De Seigneux","year":"2010","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD014820.pub2-BIB0005|cit5","first-page":"599A","article-title":"Recombinant human erythropoietin in patients having cardiac surgery: does it prevent acute kidney injury? [abstract no: SA-PO2133]","volume":"20","author":"Saudan","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2369-13-132","article-title":"Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study","volume":"13","author":"Seigneux","year":"2012","journal-title":"BMC Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD014820.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ki.2010.555","article-title":"Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function","volume":"79","author":"Endre","year":"2011","journal-title":"Kidney International"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD014820.pub2-BIB0008|cit8","first-page":"296A","article-title":"Acute high-dose intravenous epoetin does not increased blood pressure in critically III patients with acute kidney injury [abstract no: TH-PO801]","volume":"22","author":"Endre","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD014820.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ki.2010.25","article-title":"Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)","volume":"77","author":"Endre","year":"2010","journal-title":"Kidney International"},{"issue":"7","key":"10.1002\/14651858.CD014820.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2215\/CJN.08531109","article-title":"Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit","volume":"5","author":"Pickering","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5414\/CN107673","article-title":"High-dose intravenous epoetin does not increase blood pressure in critically ill patients with acute kidney injury","volume":"79","author":"Ralib","year":"2013","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4244\/EIJ-D-16-00591","article-title":"Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial","volume":"13","author":"Urena","year":"2017","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jacc.2016.04.040","article-title":"Early high-dose erythropoietin therapy after out-of-hospital cardiac arrest: a multicenter, randomized controlled trial","volume":"68","author":"Cariou","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD014820.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ckj\/sfz068","article-title":"Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial","volume":"13","author":"Guillemet","year":"2020","journal-title":"Clinical Kidney Journal"},{"issue":"10012","key":"10.1002\/14651858.CD014820.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/S0140-6736(15)00386-4","article-title":"Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial","volume":"386","author":"Nichol","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0016|cit16","first-page":"39","article-title":"Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial","volume":"16","author":"Nichol","year":"2015","journal-title":"Trials [Electronic Resource]"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0017|cit17","first-page":"501","article-title":"Statistical analysis plan for the erythropoietin in traumatic brain injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury","volume":"15","author":"Presneill","year":"2014","journal-title":"Trials [Electronic Resource]"},{"issue":"4","key":"10.1002\/14651858.CD014820.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1097\/CCM.0000000000004853","article-title":"A post hoc analysis of osmotherapy use in the erythropoietin in traumatic brain injury study-associations with acute kidney injury and mortality","volume":"49","author":"Skrifvars","year":"2021","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014820.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/aas.13244","article-title":"Erythropoietin in traumatic brain injury associated acute kidney injury: a randomized controlled trial","volume":"63","author":"Skrifvars","year":"2019","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD014820.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ALN.0000000000000321","article-title":"Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial)","volume":"121","author":"Dardashti","year":"2014","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1186\/cc13081","article-title":"Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety","volume":"17","author":"Kim","year":"2013","journal-title":"Critical Care London, England)"},{"issue":"2","key":"10.1002\/14651858.CD014820.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.athoracsur.2015.08.007","article-title":"Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest","volume":"101","author":"Kim","year":"2016","journal-title":"Annals of Thoracic Surgery"},{"issue":"3-4","key":"10.1002\/14651858.CD014820.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000106071","article-title":"Effect of darbepoetin alfa on physical function in patients undergoing surgery for colorectal cancer. A randomized, double-blind, placebo-controlled study","volume":"71","author":"Norager","year":"2007","journal-title":"Oncology"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00467-008-1087-4","article-title":"Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial","volume":"24","author":"Pape","year":"2009","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpeds.2021.01.031","article-title":"The impact of erythropoietin on short- and long-term kidney-related outcomes in neonates of extremely low gestational age. Results of a multicenter, double-blind, placebo-controlled randomized clinical trial","volume":"232","author":"Askenazi","year":"2021","journal-title":"Journal of Pediatrics"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD014820.pub2-BIB0026|cit26","first-page":"80","article-title":"Does erythropoietin (EPO) protect extremely low gestational age neonates (ELGANs) against AKI? [abstract no: SA-OR009]","volume":"30","author":"Askenazi","year":"2019","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD014820.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2215\/CJN.18841220","article-title":"Severe acute kidney injury and mortality in extremely low gestational age neonates","volume":"16","author":"Hingorani","year":"2021","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD014820.pub2-BIB0028|cit28","first-page":"34","article-title":"Effect of erythropoietin (EPO) on outcomes at 24-26 months in extremely low gestational age neonates (ELGAN) [abstract no: TH-OR124]","volume":"30","author":"Hingorani","year":"2019","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD014820.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/nep.12609","article-title":"Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: a randomized controlled trial","volume":"21","author":"Shema-Didi","year":"2016","journal-title":"Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3346\/jkms.2012.27.5.506","article-title":"Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting","volume":"27","author":"Oh","year":"2012","journal-title":"Journal of Korean Medical Science"},{"issue":"3","key":"10.1002\/14651858.CD014820.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000223229","article-title":"Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study","volume":"30","author":"Song","year":"2009","journal-title":"American Journal of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD014820.pub2-BIB0032|cit32","first-page":"41A","article-title":"The effect of erythropoietin on renal function after coronary artery bypass surgery: a prospective randomized clinical trial [abstract no: SA-FC032]","volume":"18","author":"Song","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2369-14-136","article-title":"Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial","volume":"14","author":"Tasanarong","year":"2013","journal-title":"BMC Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD014820.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jtcvs.2009.10.012","article-title":"Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study","volume":"139","author":"Weltert","year":"2010","journal-title":"Journal of Thoracic & Cardiovascular Surgery"},{"issue":"7","key":"10.1002\/14651858.CD014820.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/trf.13027","article-title":"A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial","volume":"55","author":"Weltert","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/ALN.0b013e318232004b","article-title":"Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery","volume":"115","author":"Yoo","year":"2011","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12882-022-02727-5","article-title":"Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial","volume":"23","author":"Aoun","year":"2022","journal-title":"BMC Nephrology"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13104-014-0964-0","article-title":"rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial","volume":"8","author":"Coupes","year":"2015","journal-title":"BMC Research Notes"},{"issue":"2","key":"10.1002\/14651858.CD014820.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/TA.0b013e31817f2c6e","article-title":"Improved survival of critically ill trauma patients treated with recombinant human erythropoietin","volume":"65","author":"Napolitano","year":"2008","journal-title":"Journal of Trauma-Injury Infection & Critical Care"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0040|cit40","unstructured":"Singh AK Erythropoietin in Radio contrast Induced Nephropathy (ERIN) Trial https:\/\/clinicaltrials.gov\/study\/NCT00476619"},{"issue":"4","key":"10.1002\/14651858.CD014820.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00345-011-0760-6","article-title":"Intra-operative erythropoietin during laparoscopic partial nephrectomy is not renoprotective","volume":"30","author":"Olweny","year":"2012","journal-title":"World Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.ajkd.2005.07.034","article-title":"Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy","volume":"46","author":"Park","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1002\/14651858.CD014820.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/01.CCM.0000233873.17954.42","article-title":"Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Silver","year":"2006","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0044|cit44","first-page":"29","article-title":"Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study","volume":"161","author":"Tsuji","year":"1995","journal-title":"European Journal of Surgery"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0045|cit45","unstructured":"Murday A The use of erythropoietin in cardiac surgery to protect against ischaemia-related injury in kidney and other organ systems controlled-trials.com\/ISRCTN89080534"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MNH.0b013e32831a9dde","article-title":"Erythropoietin and renoprotection","volume":"18","author":"Bahlmann","year":"2009","journal-title":"Current Opinion in Nephrology & Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD014820.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Critical Care (London, England)"},{"issue":"6","key":"10.1002\/14651858.CD014820.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MCC.0b013e328317ee82","article-title":"Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury","volume":"14","author":"Bernhardt","year":"2008","journal-title":"Current Opinion in Critical Care"},{"issue":"1-4","key":"10.1002\/14651858.CD014820.pub2-BIB0049|cit49","first-page":"89","article-title":"Clinical trial endpoints in acute kidney injury","volume":"127","author":"Shaw","year":"2014","journal-title":"Nephron"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jacc.2016.04.040","article-title":"Early high-dose erythropoietin therapy after out-of-hospital cardiac arrest: a multicenter, randomized controlled trial","volume":"68","author":"Cariou","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD014820.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.2013.118","article-title":"Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the beta-common receptor","volume":"84","author":"Coldewey","year":"2013","journal-title":"Kidney International"},{"issue":"11","key":"10.1002\/14651858.CD014820.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2215\/CJN.00950117","article-title":"Health care costs associated with AKI","volume":"12","author":"Collister","year":"2017","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12882-017-0438-4","article-title":"Erythropoiesis stimulating agents and reno-protection: a meta-analysis","volume":"18","author":"Elliott","year":"2017","journal-title":"BMC Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-022-04253-0","article-title":"The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis","volume":"27","author":"Fazzini","year":"2023","journal-title":"Critical Care (London, England)"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2215\/CJN.09131209","article-title":"2009: a requiem for rHuEPOs--but should we nail down the coffin in 2010?","volume":"5","author":"Goldsmith","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"7650","key":"10.1002\/14651858.CD014820.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD014820.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD014820.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0059|cit59","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD014820.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2007.00818.x","article-title":"Erythropoietin after a century of research: younger than ever","volume":"78","author":"Jelkmann","year":"2007","journal-title":"European Journal of Haematology"},{"issue":"107","key":"10.1002\/14651858.CD014820.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ki.5002482","article-title":"Antioxidative effects of erythropoietin","volume":"72","author":"Katavetin","year":"2007","journal-title":"Kidney International - Supplement"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0062|cit62","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney International Supplements"},{"issue":"7","key":"10.1002\/14651858.CD014820.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfu016","article-title":"The economic impact of acute kidney injury in England","volume":"29","author":"Kerr","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD014820.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses [Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219]","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014820.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"ITC66","DOI":"10.7326\/AITC201711070","article-title":"Acute kidney injury [Erratum in: Ann Intern Med. 2018 Jan 2;168(1):84]","volume":"167","author":"Levey","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014820.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1190\u20139","DOI":"10.1007\/s00134-019-05686-y","article-title":"Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis","volume":"45","author":"Litton","year":"2019","journal-title":"Intensive Care Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014820.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Statistical Methods in Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD014820.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Critical Care (London, England)"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2110-5820-1-3","article-title":"Erythropoietin (EPO) in acute kidney injury","volume":"1","author":"Moore","year":"2011","journal-title":"Annals of Intensive Care"},{"issue":"11","key":"10.1002\/14651858.CD014820.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.hlc.2016.04.016","article-title":"Characterising the role of perioperative erythropoietin for preventing acute kidney injury after cardiac surgery: systematic review and meta-analysis","volume":"25","author":"Penny-Dimri","year":"2016","journal-title":"Heart, Lung & Circulation"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0071|cit71","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014820.pub2-BIB0072|cit72","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD014820.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/nep.12609","article-title":"Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: a randomized controlled trial","volume":"21","author":"Shema-Didi","year":"2015","journal-title":"Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD014820.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/aas.13244","article-title":"Erythropoietin in traumatic brain injury associated acute kidney injury: a randomized controlled trial","volume":"63","author":"Skrifvars","year":"2019","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD014820.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"World incidence of AKI: a meta-analysis","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"1","key":"10.1002\/14651858.CD014820.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ejcts\/ezu378","article-title":"Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials","volume":"48","author":"Tie","year":"2015","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD014820.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/FJC.0000000000000229","article-title":"Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Zhao","year":"2015","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD014820.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014820","article-title":"Erythropoiesis-stimulating agents for preventing acute kidney injury","author":"Nishiwaki","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T10:17:46Z","timestamp":1754561866000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014820.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":78,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014820.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}